| abstract |
The present invention relates to a pharmaceutical composition or an anticancer adjuvant for use in prevention or treating cancer, the composition or adjuvant comprising both of: streptonigrin; and at least one additional anticancer agent selected from the group consisting of bortezomib, rapamycin, and gemcitabine. In addition, the present invention relates to a method for prevention or treatment of cancer, the method comprising a step of administering to a patient a pharmaceutical composition comprising both of: streptonigrin; and at least one additional anticancer agent selected from the group consisting of bortezomib, rapamycin, and gemcitabine. Therefore, the composition comprising all of streptonigrin and other anticancer agents according to the present invention has the excellent effect of inhibiting the growth of cancer cells, particularly, breast cancer cells and as such, can be effectively used in a cancer prevention or treatment composition or a cancer prevention or treatment method using same. |